Clinical Trial Update: Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated lacosamide as the first add-on antiseizure medication for patients with partial-onset seizures; results were posted after study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• lacosamide (Vimpat) (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Partial Epilepsies | Phase 4 | Status: COMPLETED | Results posted: 2014-05-01